CannabiSalud, Latin America’s symposium on medical cannabis, will present a free mini-conference, “Cannabis: History, Uses, and Benefits,” in Puerto Vallarta on Thursday, April 26th. Presenters include local neuropsychologist Maureen Priestley, Director of Pasos Adelante Puerto Vallarta, and Lorena Beltran, entrepreneur and director of CannabiSalud. The Puerto Vallarta mini-conference will take place at the Centro Universitario de la Costa at 6:30pm. The event is directed in particular at medical professionals, but the general public is also invited to attend.
“CannabiSalud intends to educate and support medical personnel who see themselves as trapped between patients demanding cannabis-based treatments and ignorance about where to begin,” says Beltran, the principal force behind CannabiSalud, the first event of its kind in Latin America.
CannabiSalud’s historic inaugural symposium took place last year in Guadalajara, featuring scientists and industry leaders from around the world, including Israel, United States, Brazil, Spain, and Colombia. The next CannabiSalud symposium is scheduled to take place this year with an equally impressive list of speakers in Mexico City on June 8th and 9th in Expo Reforma.
Maureen “Mimi” Priestley is the director of Pasos Adelante Puerto Vallarta, a clinic dedicated to the treatment of autism, learning disabilities, epilepsy, and other conditions. A speaker at the first CannabiSalud symposium, she is the author of 22 books and a frequent lecturer at conferences around the world. Recently, she has begun to focus on medicinal cannabis.
Priestley says “medical professionals need to come out of the cannabis closet.”
Currently, cannabis is in legal limbo in Mexico. In April 2017, almost exactly a year ago to the day, Mexico authorized reforms to the General Health Laws and Federal Penal Code that essentially ended cannabis prohibition at a federal level. However, COFEPRIS, Mexico’s government health organization, has failed to issue any rules regarding the new legislation, so critical legal details remain unclear.
“In Mexico we are still waiting on COFEPRIS to issue its regulations,” says Beltran. “Nevertheless, the cannabis movement and the demand for treatments continues to grow. People are confused and think commercial business is now legal, buying products that often are of inferior quality for consumption. A variety of problems are emerging due to COFEPRIS’ foot-dragging that will be difficult to control later.”
While governmental agencies continue to dawdle, the movement for cannabis medicine marches forward, and CannabiSalud is leading the way. For more information, visit CannabiSalud.com.